MarketingRx roundup: Arcutis joins crowded psoriasis ad market on TV; Merck, GSK, Moderna highlight immunization month
Arcutis is jumping into the psoriasis TV ad market with its first-ever commercial for Zorvye, its non-steroid cream approved in July 2022. The message behind the ad called “The Cream That Can” is about making the topical management of plaque psoriasis simple, the company said in a press release.
The ad will air on leading on-demand streaming services, aiming to reach many of the now more than 130 million commercial patients who have access to Zoryve (roflumilast), the biopharma said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.